RECENT HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISIONS ACROSS THE GLOBE: A FOCUS ON NON-SMALL CELL LUNG CANCER: RESULTS, RATIONALE, AND TRENDS

被引：0
|
作者：
Kanaskar, A. [1 ]
Campbell, D. [1 ]
Campbell, C. M. [1 ]
Riggs, K. [1 ]
Meyer, K. L. [1 ]
机构：
[1] Xcenda, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN353
引用
收藏
页码：S504 / S505
页数：2
相关论文
共 50 条
  • [21] Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Goss, G.
    Blumenschein, G., Jr.
    CANCER TREATMENT REVIEWS, 2012, 38 (03) : 173 - 184
  • [22] Erlotinib: Recent clinical results and ongoing studies in non-small cell lung cancer
    Perez-Soler, Roman
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4589S - 4592S
  • [23] RATIONALE FOR THE USE OF CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    MILLER, TP
    SEMINARS IN ONCOLOGY, 1990, 17 (04) : 11 - 13
  • [24] WHAT IS THE REGULATORY AND HTA LANDSCAPE OF NON-SMALL CELL LUNG CANCER DRUGS ACROSS THE EU5 COUNTRIES?
    Inumerable, R. V. F.
    Rubinstein, J.
    Lurie, B. F.
    Guill, E. W.
    VALUE IN HEALTH, 2019, 22 : S508 - S508
  • [25] Recent trends in resection rates among non-small cell lung cancer patients in England
    Riaz, Sharma P.
    Linklater, Karen M.
    Page, Richard
    Peake, Michael D.
    Moller, Henrik
    Luechtenborg, Margreet
    THORAX, 2012, 67 (09) : 811 - 814
  • [26] Current trends in imaging of non-small cell lung cancer
    Scheffler, M.
    Wolf, J.
    ONKOLOGE, 2009, 15 (05): : 496 - +
  • [27] Surgery for non-small cell lung cancer - new trends
    Waller, DA
    LUNG CANCER, 2001, 34 : S133 - S136
  • [28] Clinical Upstaging of Non-Small Cell Lung Cancer That Extends Across the Fissure: Implications for Non-Small Cell Lung Cancer Staging
    Joshi, Vijay
    McShane, James
    Page, Richard
    Carr, Martyn
    Mediratta, Neeraj
    Shackcloth, Michael
    Poullis, Michael
    ANNALS OF THORACIC SURGERY, 2011, 91 (02): : 350 - 354
  • [29] IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort
    Morfouace, M.
    Schulz, D.
    Eling, N.
    Marzetta, F.
    Loizides, C.
    Rusakiewicz, S.
    Liechti, R.
    Hong, H. S.
    Robert, M-S.
    Bironzo, P.
    Cufer, T.
    Oselin, K.
    Cloarec, N.
    Oliveira, J.
    Bodenmiller, B.
    Besse, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1164 - S1164
  • [30] TREATMENT LANDSCAPE AND KEY DRIVERS FOR HTA DECISIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITHOUT EGFR OR ALK ALTERATIONS
    Henry, A.
    Hollier-Hann, G.
    Ralston, S.
    VALUE IN HEALTH, 2019, 22 : S507 - S507
12345